The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.


Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Trump Administration Expands Global Gag Rule, Restricting U.S. Foreign Aid to Diversity and Gender Programs
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Faith Leaders Arrested on Capitol Hill During Protest Against Trump Immigration Policies and ICE Funding
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Sam Altman Criticizes ICE Enforcement as Corporate Leaders Call for De-Escalation
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Trump Appoints Colin McDonald as Assistant Attorney General for National Fraud Enforcement
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
ICE Blocked From Entering Ecuador Consulate in Minneapolis During Immigration Operation
Pemex Halts Planned Crude Oil Shipment to Cuba Amid Rising US Pressure
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



